161 related articles for article (PubMed ID: 38662286)
1. Predictive Model to Identify the Long Time Survivor in Patients with Glioblastoma: A Cohort Study Integrating Machine Learning Algorithms.
Yang XL; Zeng Z; Wang C; Sheng YL; Wang GY; Zhang FQ; Lian X
J Mol Neurosci; 2024 Apr; 74(2):48. PubMed ID: 38662286
[TBL] [Abstract][Full Text] [Related]
2. Integrated genomic analysis of survival outliers in glioblastoma.
Peng S; Dhruv H; Armstrong B; Salhia B; Legendre C; Kiefer J; Parks J; Virk S; Sloan AE; Ostrom QT; Barnholtz-Sloan JS; Tran NL; Berens ME
Neuro Oncol; 2017 Jun; 19(6):833-844. PubMed ID: 27932423
[TBL] [Abstract][Full Text] [Related]
3. Establishment and validation of an immune-based prognostic score model in glioblastoma.
Qin Z; Zhang X; Chen Z; Liu N
Int Immunopharmacol; 2020 Aug; 85():106636. PubMed ID: 32534425
[TBL] [Abstract][Full Text] [Related]
4. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
[TBL] [Abstract][Full Text] [Related]
5. Molecular features of glioblastomas in long-term survivors compared to short-term survivors-a matched-pair analysis.
Sommerlath VN; Buergy D; Etminan N; Brehmer S; Reuss D; Sarria GR; Guiot MC; Hänggi D; Wenz F; Petrecca K; Giordano FA
Radiat Oncol; 2022 Jan; 17(1):15. PubMed ID: 35073955
[TBL] [Abstract][Full Text] [Related]
6. Molecular profiling of short-term and long-term surviving patients identifies CD34 mRNA level as prognostic for glioblastoma survival.
Michaelsen SR; Urup T; Olsen LR; Broholm H; Lassen U; Poulsen HS
J Neurooncol; 2018 May; 137(3):533-542. PubMed ID: 29305787
[TBL] [Abstract][Full Text] [Related]
7. Molecular profiling of long-term IDH-wildtype glioblastoma survivors.
Burgenske DM; Yang J; Decker PA; Kollmeyer TM; Kosel ML; Mladek AC; Caron AA; Vaubel RA; Gupta SK; Kitange GJ; Sicotte H; Youland RS; Remonde D; Voss JS; Fritcher EGB; Kolsky KL; Ida CM; Meyer FB; Lachance DH; Parney IJ; Kipp BR; Giannini C; Sulman EP; Jenkins RB; Eckel-Passow JE; Sarkaria JN
Neuro Oncol; 2019 Nov; 21(11):1458-1469. PubMed ID: 31346613
[TBL] [Abstract][Full Text] [Related]
8. Radiogenomic analysis of hypoxia pathway is predictive of overall survival in Glioblastoma.
Beig N; Patel J; Prasanna P; Hill V; Gupta A; Correa R; Bera K; Singh S; Partovi S; Varadan V; Ahluwalia M; Madabhushi A; Tiwari P
Sci Rep; 2018 Jan; 8(1):7. PubMed ID: 29311558
[TBL] [Abstract][Full Text] [Related]
9. LOC283731 promoter hypermethylation prognosticates survival after radiochemotherapy in IDH1 wild-type glioblastoma patients.
Mock A; Geisenberger C; Orlik C; Warta R; Schwager C; Jungk C; Dutruel C; Geiselhart L; Weichenhan D; Zucknick M; Nied AK; Friauf S; Exner J; Capper D; Hartmann C; Lahrmann B; Grabe N; Debus J; von Deimling A; Popanda O; Plass C; Unterberg A; Abdollahi A; Schmezer P; Herold-Mende C
Int J Cancer; 2016 Jul; 139(2):424-32. PubMed ID: 26934681
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Factors Associated with Long-Term Survival in Patients with Glioblastoma.
Madhugiri VS; Moiyadi AV; Shetty P; Gupta T; Epari S; Jalali R; Subeikshanan V; Dutt A; Sasidharan GM; Roopesh Kumar VR; Shankar Ganesh CV; Ramesh AS; Sathia Prabhu A
World Neurosurg; 2021 May; 149():e758-e765. PubMed ID: 33540096
[TBL] [Abstract][Full Text] [Related]
11. Machine-learning based radiogenomics analysis of MRI features and metagenes in glioblastoma multiforme patients with different survival time.
Liao X; Cai B; Tian B; Luo Y; Song W; Li Y
J Cell Mol Med; 2019 Jun; 23(6):4375-4385. PubMed ID: 31001929
[TBL] [Abstract][Full Text] [Related]
12. Identifying potential biomarkers for non-obstructive azoospermia using WGCNA and machine learning algorithms.
Tang Q; Su Q; Wei L; Wang K; Jiang T
Front Endocrinol (Lausanne); 2023; 14():1108616. PubMed ID: 37854191
[TBL] [Abstract][Full Text] [Related]
13. Imaging patterns predict patient survival and molecular subtype in glioblastoma via machine learning techniques.
Macyszyn L; Akbari H; Pisapia JM; Da X; Attiah M; Pigrish V; Bi Y; Pal S; Davuluri RV; Roccograndi L; Dahmane N; Martinez-Lage M; Biros G; Wolf RL; Bilello M; O'Rourke DM; Davatzikos C
Neuro Oncol; 2016 Mar; 18(3):417-25. PubMed ID: 26188015
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive molecular characterization of long-term glioblastoma survivors.
Xu H; Chen X; Sun Y; Hu X; Zhang X; Wang Y; Tang Q; Zhu Q; Song K; Chen H; Sheng X; Yao Y; Zhuang D; Chen L; Mao Y; Qin Z
Cancer Lett; 2024 May; ():216938. PubMed ID: 38734160
[TBL] [Abstract][Full Text] [Related]
15. Identification of immunologic subtype and prognosis of GBM based on TNFSF14 and immune checkpoint gene expression profiling.
Long S; Li M; Liu J; Yang Y; Li G
Aging (Albany NY); 2020 Apr; 12(8):7112-7128. PubMed ID: 32310827
[TBL] [Abstract][Full Text] [Related]
16. Differential effect of vascularity between long- and short-term survivors with IDH1/2 wild-type glioblastoma.
Álvarez-Torres MDM; Fuster-García E; Reynés G; Juan-Albarracín J; Chelebian E; Oleaga L; Pineda J; Auger C; Rovira A; Emblem KE; Filice S; Mollà-Olmos E; García-Gómez JM
NMR Biomed; 2021 Apr; 34(4):e4462. PubMed ID: 33470039
[TBL] [Abstract][Full Text] [Related]
17. A 5-gene prognostic nomogram predicting survival probability of glioblastoma patients.
Wang L; Yan Z; He X; Zhang C; Yu H; Lu Q
Brain Behav; 2019 Apr; 9(4):e01258. PubMed ID: 30859746
[TBL] [Abstract][Full Text] [Related]
18. Molecular Predictors of Long-Term Survival in Glioblastoma Multiforme Patients.
Lu J; Cowperthwaite MC; Burnett MG; Shpak M
PLoS One; 2016; 11(4):e0154313. PubMed ID: 27124395
[TBL] [Abstract][Full Text] [Related]
19. A Risk Score Signature Consisting of Six Immune Genes Predicts Overall Survival in Patients with Lower-Grade Gliomas.
Wu Y; Peng Z; Gu S; Wang H; Xiang W
Comput Math Methods Med; 2022; 2022():2558548. PubMed ID: 35186111
[TBL] [Abstract][Full Text] [Related]
20. Deoxyhypusine hydroxylase: A novel therapeutic target differentially expressed in short-term vs long-term survivors of glioblastoma.
Ofek P; Yeini E; Arad G; Danilevsky A; Pozzi S; Luna CB; Dangoor SI; Grossman R; Ram Z; Shomron N; Brem H; Hyde TM; Geiger T; Satchi-Fainaro R
Int J Cancer; 2023 Aug; 153(3):654-668. PubMed ID: 37141410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]